|
A user facility¿s registered nurse (rn) reported that an internal dialyzer blood leak occurred during a patient¿s hemodialysis (hd) treatment.The leak was not visually observed.The machine, a fme 2008t machine, alarmed appropriately with a blood leak alarm.Blood leak test strips were used and tested positive for the presence of blood.A fme bloodline was in use.There was no obvious defect or damage seen on the dialyzer.The patient¿s estimated blood loss (ebl) was approximately 500ml.The patient was restarted on the same machine and treatment completed successfully with new supplies.There was no patient injury or medical intervention required due to the reported event.The complaint device is not available to be returned to the manufacturer for evaluation.Three photos have been provided.
|
|
Plant investigation: as the device was not returned to the manufacturer, a physical evaluation could not be performed.However, three photographs were provided by the customer.The first photograph showed a dialyzer on its side with the ogden provided dialyzer caps attached to the dialysate ports.There was visible blood pooled on the outside of the fibers in the bell housing and blood was present near the middle of the housing.The second photograph showed the same dialyzer from a different angle where the blood was visible on the outside of the fibers, pooled in the bell housing, indicative of an internal blood leak.The third photograph showed the product label.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.The investigation into the complaint was able to confirm the reported event based on the provided photographs.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas for vision systems and blood leak reduction are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
|